TickerFacts.

Compare

Traws Pharma, Inc. vs Shuttle Pharmaceuticals Holdings, Inc. vs Longeveron Inc. vs Lantern Pharma Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearTraws Pharma, Inc.
TRAWRevenue covers only part of its income (partial revenue)		Shuttle Pharmaceuticals Holdings, Inc.
SHPH		Longeveron Inc.
LGVN		Lantern Pharma Inc.
LTRN
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenuen/an/a$1.20Mn/a
Revenue growth (YoY)n/an/a-49.9%n/a
Gross marginn/an/a67.0%n/a
Operating marginn/an/an/mn/a
Net marginn/an/an/mn/a
Net income$9.17M-$11.72M-$22.70M-$17.12M
EPS (Diluted)$0.82-$7.16-$1.29-$1.57
Operating cash flow-$18.18M-$9.48M-$18.64M-$15.68M
Free cash flow-$20.77Mn/a-$18.89M-$15.68M
Cash & equivalentsn/a$334.0K$4.66M$4.42M
Total assets$10.62M$10.48M$10.26M$11.04M
Total liabilities$11.25M$8.22M$4.59M$4.50M
Shareholders' equity-$629.0K$2.25M$5.67M$6.53M
Return on year-end equityn/a-519.9%-400.1%-262.0%
Shares outstanding9.07M2.02Mn/a11.25M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearTraws Pharma, Inc.Shuttle Pharmaceuticals Holdings, Inc.Longeveron Inc.Lantern Pharma Inc.
Latestn/an/a$1.20M
Ended 2025-12-31		n/a
1 year earliern/an/a$2.39M
Ended 2024-12-31		n/a
2 years earliern/an/a$709.0K
Ended 2023-12-31		n/a
3 years earliern/an/a$1.22M
Ended 2022-12-31		n/a
4 years earliern/an/a$1.31M
Ended 2021-12-31		n/a